生物技术企业接力创新中的知识产权运营模式研究——以生物制药为例  

Study on the Operation Models of the Intellectual Property Rights of the Bio-technology Enterprises during the Relay Innovation——Taking Bio-pharmaceutical for Example

作　　者：冯薇[1] 银路[1] 李天柱[2] 马佳[2] 

机构地区：[1]电子科技大学,成都611731 [2]辽宁科技大学,鞍山114051

出　　处：《电子科技大学学报（社科版）》2014年第6期87-91,100,共6页Journal of University of Electronic Science and Technology of China(Social Sciences Edition)

基　　金：国家社会科学基金青年基金项目(12CGL016);国家自然科学基金面上项目(71372121);教育部人文社会科学研究项目青年基金项目(11YJCZH033);成都市科技局软科学项目(12RKYB029ZF);广义虚拟经济研究专项资助项目(GX2012-1020(M))

摘　　要：现代生物技术的创新过程具有明显的"接力创新"的特质,而知识产权运营对于相关企业在"接力创新"中获利显得尤为重要。在生物技术的"接力创新"过程中,基于不同的创新阶段和时机,专家型公司和核心公司可能选择不同的接力模式。在已有研究的基础上,以生物制药企业为样本,深入探讨两类公司不同接力方式下的不同知识产权运营模式,为我国现代生物技术企业的知识产权管理和实践提供有效借鉴。The innovation process of the modem bio-technology is characterized by ＂relay innovation＂, meanwhile, the operation of the intellectual property rights is especially important to the relative enterprises. During the process of the relay innovation, the expert company and the core company will choose different relay modes based on the different stage and timing of the innovation. On the basis of the existing research, taking the bio-pharmaceutical enterprises as example, it discusses thoroughly the different operation modes of the intellectual property rights of the expert company and the core company under the different ways of relay cooperation. We are looking forward to providing effective references to the modem bio-technology enterprises in China for the intellectual property rights management and practice.

关 键 词：现代生物技术 接力创新 知识产权运营 

分 类 号：D923[政治法律—民商法学]